Issue Date: April 21, 2014 | Web Date: April 18, 2014
Drug Development Deal Sours For University, Biotech Firm
Partnerships between universities and corporations are billed as a great way to turn academic discoveries into useful products and therapies, but a dispute between the University of California, Los Angeles, and a biotech firm shows they can easily turn ugly.
On April 11, UCLA filed a lawsuit against San Francisco-based Medivation accusing the company of withholding promised profits on a cancer drug discovered by UCLA researchers. The suit follows by less . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society